天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

ChemicalBook >> journal list >> ACS Applied Materials & Interfaces >>article
ACS Applied Materials & Interfaces

ACS Applied Materials & Interfaces

IF: 8.3
Download PDF

4-methylumbelliferone treatment and hyaluronan inhibition as a therapeutic strategy in inflammation, autoimmunity, and cancer.

Published:23 March 2015 DOI: 10.3389/fimmu.2015.00123 PMID: 25852691
Nadine Nagy, Hedwich F Kuipers, Adam R Frymoyer, Heather D Ishak, Jennifer B Bollyky, Thomas N Wight, Paul L Bollyky

Abstract

Hyaluronan (HA) is a prominent component of the extracellular matrix at many sites of chronic inflammation, including type 1 diabetes (T1D), multiple sclerosis, and numerous malignancies. Recent publications have demonstrated that when HA synthesis is inhibited using 4-methylumbelliferone (4-MU), beneficial effects are observed in several animal models of these diseases. Notably, 4-MU is an already approved drug in Europe and Asia called "hymecromone" where it is used to treat biliary spasm. However, there is uncertainty regarding how 4-MU treatment provides benefit in these animal models and the potential long-term consequences of HA inhibition. Here, we review what is known about how HA contributes to immune dysregulation and tumor progression. Then, we review what is known about 4-MU and hymecromone in terms of mechanism of action, pharmacokinetics, and safety. Finally, we review recent studies detailing the use of 4-MU to treat animal models of cancer and autoimmunity.

Substances (2)

Related products
Procduct Name CAS Molecular Formula Supplier Price
4-Methylumbelliferone 90-33-5 C10H8O3 664 suppliers $9.00-$801.00
Hyaluronan (Ultra Low MW) 3 suppliers Inquiry

Similar articles

IF:5.7

4-Methylumbelliferone Inhibits Angiogenesis in Vitro and in Vivo

Journal of Agricultural and Food Chemistry Javier A. García-Vilas, Ana R. Quesada,etc Published: 12 April 2013
IF:3.8

4-Methylumbelliferone enhances the effects of chemotherapy on both temozolomide-sensitive and resistant glioblastoma cells.

Scientific Reports Matías A Pibuel,?Daniela Poodts,etc Published: 8 June 2023
IF:5.9

Creatine monohydrate as a therapeutic aid in muscular dystrophy.

Nutrition reviews Jared Pearlman,?R. Fielding,etc Published: 1 February 2006